Drugs / ATB-320
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06933524 | Dec 2025 → Dec 2028 expected | cancer | Autotelicbio | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ATB-320 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06933524 ↗ |
| Route | Intravenous | “IV infusion” NCT06933524 ↗ |